Navana Pharmaceuticals Limited, a listed pharmaceutical and chemical company, plans to raise 150 crores through a bond issuance. The partially convertible bonds will have a tenure of 5 years and carry a floating interest rate. The company aims to utilize the funds for repaying bank loans. The approval of the Bangladesh Securities and Exchange Commission (BSEC) and shareholders is required for the bond issue, which will be discussed at a special general meeting scheduled for July 31. In other news, the company’s share price in the Dhaka Stock Exchange experienced a 7.51 percent decline. Navana Pharmaceuticals is categorized as ‘A’ and has a paid-up capital of Tk 107 crore 41 lakh 60 thousand.
Navana Pharmaceuticals to Raise 150 Crores by issuing bonds
Company Intelligence Tag:
Source for more details: